Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,017,701
+$583,950 QoQ
Shares Held
19,940
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,311
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. ABBV ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,839 | $1,243,059 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,017,701 | 19,940 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,433,751 | 20,386 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,510,621 | 19,741 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,600,931 | 19,871 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,963,915 | 21,355 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,996,423 | 23,847 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,149,828 | 23,353 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,599,704 | 23,292 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,878,924 | 22,615 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $4,124,747 | 22,651 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,489,304 | 22,516 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,461,024 | 23,219 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,088,685 | 22,925 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,742,485 | 23,483 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,709,272 | 22,952 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,272,979 | 24,387 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,691,921 | 24,105 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,420,521 | 21,100 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,528,595 | 18,675 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,987,828 | 18,428 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,125,967 | 18,874 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,067,434 | 19,104 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,117,605 | 19,763 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,956,935 | 22,342 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,411,006 | 24,557 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,656,599 | 21,743 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||